GRAIL Archives | McKesson Ventures

GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease

...

GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Cleveland Clinic Joins Interventional Study Using GRAIL’s Multi-Cancer Early Detection Test to Help Guide Clinical Care

Breakthroughs with the other C-word

Biotech startup bringing 400 jobs to Durham after landing incentive package

GRAIL to Participate in BofA Securities 2020 Health Care Conference

GRAIL Announces $390 Million Series D Financing

GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting

GRAIL Announces Validation of Its Multi-Cancer Early Detection Test Published in Annals of Oncology

1
2
3
4
5